medline.ch Neurologie Parkinson

	Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's disease. Alzheimers Dement Mirza SS, Duff-Canning S, Mapstone M, Fox S, Black SE, Binns MA, Breen DP, Fishman KN, Grimes DA, Lang AE, Levine B, McLaughlin PM, Troyer AK, Masellis M, Marras C. PMID: 41388800 [PubMed - indexed for MEDLINE]
	LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease. Mov Disord Lang AE, Hauser RA, Kalia LV, Hersh B, Berger Z, Arenas RL, Paisan-Ruiz C, Fraser K, Jennings D, Kluss JH, Huntwork-Rodriguez S, Henry AG, Greenamyre JT. PMID: 41388619 [PubMed - as supplied by publisher]
	MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease. Mov Disord Clin Pract Rábano-Suárez P, Monje MHG, Vizcarra JA, Paul SS, Avión S, Morse M, Skorvanek M, Tosin MHS, Fuller RLM, Turner TH, Dekker MCJ, Hall DA, Bergmann K, Cedarbaum JM, Maetzler W, Espay AJ, Martínez-Martín P, Stebbins GT, Mestre TA, Sánchez-Ferro Á, MDSe. PMID: 41388609 [PubMed - as supplied by publisher]
	Impulse control disorders and dopamine receptor agonism in Parkinson's disease patients: Clinical implications. Parkinsonism Relat Disord Tangedal NM, Tysnes OB. PMID: 41387037 [PubMed - as supplied by publisher]
	Transcriptomic analysis of plasma small extracellular vesicles identifies potential diagnostic biomarkers for Parkinson's disease dementia. Parkinsonism Relat Disord Rajkumar AP, Hye A, Tan SF, Green H, Killick R, Nizamudeen Z, Isik FB, Figueredo G, Ballard C, Svenningsson P, Aarsland D. PMID: 41385896 [PubMed - as supplied by publisher]
	Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease. Neurology Li CH, Fan SP, Chen PS, Chang YY, Lan MY, Wu YR, Hsiao IT, Chiang HL, Cheng CY, Lee TL, Chang HC, Chang CC, Hsu JL, Huang CW, Lu CS, Lin CH. PMID: 41385755 [PubMed - indexed for MEDLINE]
	A small-scale study on dancing for people living with Parkinson's disease. PLoS One Björkdahl A, Fristedt S, Filipowicz K, Bergman P, Johansson IK, Santos Tavares Silva I. PMID: 41385586 [PubMed - indexed for MEDLINE]
	Safety and feasibility of implementing gym-based strength training for people with early onset Parkinson's disease: a phase 1 trial. Disabil Rehabil Harris DM, Thwaites C, Callisaya ML, Mouer R, Blazé R, Clifford AM, Morris ME. PMID: 41385281 [PubMed - as supplied by publisher]
	Explainable 3D CNNs link regional and network level disruption in early Parkinson's MRIs to symptom progression. bioRxiv Moroze E, Zikopoulos B, Yazdanbakhsh A. PMID: 41383753 [PubMed]
	20â€…Hz beta stimulation of the subthalamic nucleus improves response inhibition in Parkinson's disease. Brain Commun Kricheldorff J, Sauer T, Witt K. PMID: 41383649 [PubMed]
	From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson's disease. Front Immunol Tu R, Han Z, Zhang H, Jia X, Sun T, Liu H, Li J, Tang M, Wang S. PMID: 41383617 [PubMed - indexed for MEDLINE]
	A multimodal MRI framework employing machine learning for detecting beginning cognitive impairment in Parkinson's disease. Front Neurosci Balßuweit K, Bublak P, Finke K, Ruiz-Rizzo AL, Wagner F, Klingner C, Brodoehl S. PMID: 41383382 [PubMed]
	Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co-modified polymer nanoparticles. Neuroprotection Hanumanthappa R, Parthasarathy A, Heggannavar GB, Pc K, Nanjaiah H, Kumbhar R, Devaraju KS. PMID: 41383377 [PubMed]
	Complementary therapies intervention in Parkinson's disease: systematic review and meta-analysis. Front Neurol Sabbadin F, Geraci M, Nieddu L, D'Imperio D, Pregnolato G, Cacciante L. PMID: 41383242 [PubMed]
	Bridging the gap in Parkinson's disease research: from general pathophysiology to advanced 3d cell culture models. Cell Commun Signal Keles B, Rumman B, Samarie MAJA, Gürsoy Özdemir Y, Öztop Cakmak Ö, Akyoldas G, Ertan S, Sokullu E. PMID: 41382222 [PubMed - in process]
	Dynamic context-aware multi-modal deep learning for longitudinal prediction of Parkinson's disease progression. Sci Rep Dehghanghanatkaman A. PMID: 41381668 [PubMed - as supplied by publisher]
	Causal associations between cognitive impairments and retinal diseases: A two-sample Mendelian randomization study. J Int Med Res Shi Q, Zhan D, Wang W, Wu X, Sheng S, Wang Y. PMID: 41381091 [PubMed - indexed for MEDLINE]
	Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson's disease. Neuroscience Mohamed YA, Ahmed Nadeem AA, Ismail LM, Ghallab YK, Ouédraogo RJ, Elhelw J, Ahmed MZ, Tharwat EK. PMID: 41380953 [PubMed - as supplied by publisher]
	Hypokinetic Dysarthria in Parkinson's Disease: Assessment and Treatment Practices Among Algerian Speech-Language Therapists. Int J Lang Commun Disord Kaddour A, Metref O, Pinto S, Ferrat K, Mecheri Y. PMID: 41379092 [PubMed - indexed for MEDLINE]
	Prevalence of Psychosis Spectrum Symptoms, Association with Quality of Life and Caregiver Burden in Yoruba Nigerians with Parkinson's Disease: A Matched Case Control Study. West Afr J Med Ojagbemi A, Adediran O, Oyedapo-Ishola H, Olojugba T, Elugbadebo O, Imo U, Bakare AK, Taiwo F. PMID: 41378672 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 55803

Seite 1 von 2791

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung